Drugs / SLV337
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT01176201 | Jul → Oct 2010 | — | Abbott Products | Completed | No outcome recorded |
| Phase 1 | NCT00924430 | Jun → Jul 2009 | type 2 diabetes mellitus | Solvay Pharmaceuticals | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00924534 | Dec 2009 → Dec 2010 | type 2 diabetes mellitus | Abbott Products | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SLV337 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01176201 ↗ |
| Route | Oral | “after a single dose of an oral suspension of 14C-SLV337” NCT01176201 ↗ |